European healthtech VCs have never had a bigger warchest to deploy. The most recent example is the closing of Sofinnova Partners’ €472m healthtech-focused fund last month.
And that’s helped healthtech startups raise record rounds in 2021. London-based Exscientia raised nearly $1bn in multiple funding rounds this year and went public last month, Swedish telemedicine platform Kry raised $300m in April and synthetic DNA startup Touchlight raised $125m in September.
